Skip to content

Clinical trials

Completed Lupus Erythematosus, Systemic trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Status: Completed Country / region: Japan Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20102
20114
20124
20131
20141
20151
20161
20171
20184
20193
20203
20212
20223
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline7
Eli Lilly and Company3
AbbVie2
AstraZeneca2
Bristol-Myers Squibb2
UCB Pharma2
Amgen1
Daiichi Sankyo1
EMD Serono1
EMD Serono Research & Development Institute, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic32
Autoimmune Diseases3
Connective Tissue Diseases2
Immune System Diseases2
Lupus Erythematosus, Cutaneous2
Arthritis, Juvenile1
Lupus Erythematosus, Discoid1
Macrophage Activation Syndrome1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.